RE:RE:RE:I think Close to 600 thousand marketcap, as much as I would like it at that SP, not sure it will reach unless the the promo is there.
Resilience19 wrote: Simple. What will drive the sp will be 2020 revenues, which should be around $20M (based on a Marshall interview wherein he stated, when the sp was 0.17, that the P/E was around 2x), to be reflected in April's Annual report, followed by around $30m for Q1 (end-May), both mostly c-19 tests kit sales driven. If these are confirmed we can expect Q2 results (end-August) to be similar, if not higher, than Q1 results. If so, the sp will then, conservatively, move to $1.50+.
Yeehaw1 wrote: MoneyMKR72 wrote: as well as many here that April and May are going to be amazing. Anything in the .20's will be a thing of the past and never to return. What will it be first ?? Ronin?? Double/Triple up on test kit sales??Q4 and Q1 2021 Financials?? MDA co bid ?? AI taking off in Germany?? Telemedicine?? Telehealth( concierge AI)?? Imaging predictive AI (drone company)?? Ionebio approval?? Another AI contract with Lotte?? I'm really looking forward to finding out!!! GLTA
it is hard to predict the sequence order but one thing is for sure that one or more couple come back to back with very minimal gap and more importantly that the way they are dealing with things all will come eventually
stay strong and long!!!!!